Cargando…
The Ontario Cancer Research Ethics Board: a central REB that works
The Ontario Cancer Research Ethics Board (ocreb) has made its mark within Ontario as a successful, centralized, oncology-specific research ethics board. As such, ocreb has proven invaluable to principal investigators, sponsors, and study participants given its ability to reduce duplication during th...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Multimed Inc.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259427/ https://www.ncbi.nlm.nih.gov/pubmed/18317585 |
_version_ | 1782151394555330560 |
---|---|
author | Chaddah, M.R. |
author_facet | Chaddah, M.R. |
author_sort | Chaddah, M.R. |
collection | PubMed |
description | The Ontario Cancer Research Ethics Board (ocreb) has made its mark within Ontario as a successful, centralized, oncology-specific research ethics board. As such, ocreb has proven invaluable to principal investigators, sponsors, and study participants given its ability to reduce duplication during the submission process, to provide the highest quality of review, to shorten study start-up time, and to implement more efficient methods of reporting serious adverse events. |
format | Text |
id | pubmed-2259427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Multimed Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-22594272008-03-03 The Ontario Cancer Research Ethics Board: a central REB that works Chaddah, M.R. Curr Oncol Short Communication The Ontario Cancer Research Ethics Board (ocreb) has made its mark within Ontario as a successful, centralized, oncology-specific research ethics board. As such, ocreb has proven invaluable to principal investigators, sponsors, and study participants given its ability to reduce duplication during the submission process, to provide the highest quality of review, to shorten study start-up time, and to implement more efficient methods of reporting serious adverse events. Multimed Inc. 2008-01 /pmc/articles/PMC2259427/ /pubmed/18317585 Text en 2008 Multimed Inc. |
spellingShingle | Short Communication Chaddah, M.R. The Ontario Cancer Research Ethics Board: a central REB that works |
title | The Ontario Cancer Research Ethics Board: a central REB that works |
title_full | The Ontario Cancer Research Ethics Board: a central REB that works |
title_fullStr | The Ontario Cancer Research Ethics Board: a central REB that works |
title_full_unstemmed | The Ontario Cancer Research Ethics Board: a central REB that works |
title_short | The Ontario Cancer Research Ethics Board: a central REB that works |
title_sort | ontario cancer research ethics board: a central reb that works |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259427/ https://www.ncbi.nlm.nih.gov/pubmed/18317585 |
work_keys_str_mv | AT chaddahmr theontariocancerresearchethicsboardacentralrebthatworks AT chaddahmr ontariocancerresearchethicsboardacentralrebthatworks |